Explore

Trendline Trendline
Symeres Appoints Henning Steinhagen as CEO to Drive Growth

Symeres Appoints Henning Steinhagen as CEO to Drive Growth

Symeres Appoints Henning Steinhagen as CEO to Drive Growth
Trendline Trendline
Harmony Healthcare IT Appoints Brian Liddell as CEO, Ensuring Strategic Continuity

Harmony Healthcare IT Appoints Brian Liddell as CEO, Ensuring Strategic Continuity

Harmony Healthcare IT Appoints Brian Liddell as CEO, Ensuring Strategic Continuity
Trendline Trendline
Jollyes Appoints Adam Dury as CEO, Launches Five-Year Expansion Plan

Jollyes Appoints Adam Dury as CEO, Launches Five-Year Expansion Plan

Jollyes Appoints Adam Dury as CEO, Launches Five-Year Expansion Plan
Trendline Trendline
Novo Nordisk CEO Transition: Lars Fruergaard Jørgensen Steps Down Amidst Competitive Challenges

Novo Nordisk CEO Transition: Lars Fruergaard Jørgensen Steps Down Amidst Competitive Challenges

Novo Nordisk CEO Transition: Lars Fruergaard Jørgensen Steps Down Amidst Competitive Challenges
Trendline Trendline
PagerDuty Appoints John DiLullo as CEO, Signaling New Growth Phase

PagerDuty Appoints John DiLullo as CEO, Signaling New Growth Phase

PagerDuty Appoints John DiLullo as CEO, Signaling New Growth Phase
Trendline Trendline
Ravi Venkatesan Appointed CEO of Momentive Software, Succeeding Interim Leadership

Ravi Venkatesan Appointed CEO of Momentive Software, Succeeding Interim Leadership

Ravi Venkatesan Appointed CEO of Momentive Software, Succeeding Interim Leadership
Trendline Trendline
Iambic Announces Participation in Major Investor Conferences to Showcase AI-Driven Drug Development

Iambic Announces Participation in Major Investor Conferences to Showcase AI-Driven Drug Development

Iambic Announces Participation in Major Investor Conferences to Showcase AI-Driven Drug Development
Trendline Trendline
PagerDuty Appoints John DiLullo as CEO Amid Strategic Growth Plans

PagerDuty Appoints John DiLullo as CEO Amid Strategic Growth Plans

PagerDuty Appoints John DiLullo as CEO Amid Strategic Growth Plans
Trendline Trendline
MileCell Biotechnology Enhances Digital Presence and Leadership Team

MileCell Biotechnology Enhances Digital Presence and Leadership Team

MileCell Biotechnology Enhances Digital Presence and Leadership Team
Trendline Trendline
MacroGenics Sells Maryland Drug Manufacturing Plant to Bora for $122.5 Million

MacroGenics Sells Maryland Drug Manufacturing Plant to Bora for $122.5 Million

MacroGenics Sells Maryland Drug Manufacturing Plant to Bora for $122.5 Million
Trendline Trendline
Jollyes Appoints Adam Dury as CEO, Launches Five-Year Growth Strategy Targeting UK Expansion

Jollyes Appoints Adam Dury as CEO, Launches Five-Year Growth Strategy Targeting UK Expansion

Jollyes Appoints Adam Dury as CEO, Launches Five-Year Growth Strategy Targeting UK Expansion
Trendline Trendline
Bora Group Acquires MacroGenics' Maryland Manufacturing Operations for $122.5 Million

Bora Group Acquires MacroGenics' Maryland Manufacturing Operations for $122.5 Million

Bora Group Acquires MacroGenics' Maryland Manufacturing Operations for $122.5 Million